Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial. (2022)

First Author: Watson-Jones D
Attributed to:  A Dose Reduction Immunobridging Study of two HPV vaccines in Tanzanian girls funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2214-109x(22)00309-6

PubMed Identifier: 36113531

Publication URI: http://europepmc.org/abstract/MED/36113531

Type: Journal Article/Review

Volume: 10

Parent Publication: The Lancet. Global health

Issue: 10

ISSN: 2214-109X